Variant report
Variant | nsv1030781 |
---|---|
Chromosome Location | chr5:99541966-99581524 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541690888 | chr5:99542635-99542636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373537451 | chr5:99542661-99542662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560308302 | chr5:99542676-99542677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569373832 | chr5:99542687-99542688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs61382100 | chr5:99542726-99542727 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs546131116 | chr5:99542879-99542880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142224264 | chr5:99542891-99542892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116607464 | chr5:99542893-99542894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550974258 | chr5:99542900-99542901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs60716931 | chr5:99542908-99542909 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs530228378 | chr5:99542965-99542966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548365350 | chr5:99542980-99542981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs57189626 | chr5:99543003-99543004 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534092355 | chr5:99543022-99543023 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148171070 | chr5:99543065-99543066 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116014053 | chr5:99543074-99543075 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537474849 | chr5:99543080-99543081 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370210275 | chr5:99543084-99543085 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534531335 | chr5:99543122-99543123 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116263968 | chr5:99543143-99543144 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375129354 | chr5:99543166-99543167 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535555696 | chr5:99543189-99543190 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181573527 | chr5:99543218-99543219 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553202391 | chr5:99543221-99543222 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs73776415 | chr5:99546204-99546205 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs73776416 | chr5:99546260-99546261 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs73776417 | chr5:99546263-99546264 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs567349801 | chr5:99546283-99546284 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534772677 | chr5:99546299-99546300 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73776418 | chr5:99546373-99546374 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs575742749 | chr5:99546384-99546385 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545886560 | chr5:99546414-99546415 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145805286 | chr5:99546438-99546439 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73776420 | chr5:99546458-99546459 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs557747378 | chr5:99546506-99546507 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138301305 | chr5:99546511-99546512 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73158069 | chr5:99546514-99546515 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs555790331 | chr5:99546521-99546522 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374619633 | chr5:99546544-99546545 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149230741 | chr5:99546548-99546549 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544083112 | chr5:99558213-99558214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561676924 | chr5:99558220-99558221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528889477 | chr5:99558230-99558231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192803826 | chr5:99558243-99558244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541177835 | chr5:99558292-99558293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184435247 | chr5:99558336-99558337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553375023 | chr5:99558346-99558347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533015879 | chr5:99558353-99558354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187716053 | chr5:99558359-99558360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569721548 | chr5:99558441-99558442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99542600-99543400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr5:99542800-99543200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:99543000-99543400 | Active TSS | Fetal Lung | lung |
4 | chr5:99546200-99546600 | Active TSS | Fetal Heart | heart |
5 | chr5:99558200-99559200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr5:99558200-99560400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr5:99564800-99567800 | Weak transcription | Fetal Brain Male | brain |
8 | chr5:99567800-99568600 | Enhancers | Fetal Brain Male | brain |
9 | chr5:99568000-99568600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr5:99568000-99569200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr5:99568200-99569000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr5:99568200-99569000 | Enhancers | Fetal Brain Female | brain |
13 | chr5:99572200-99572600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr5:99572200-99572800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr5:99574200-99574400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr5:99578600-99579000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |